Remove Agile Remove Efficiency Remove Marketing Remove Pharmaceuticals
article thumbnail

4 Autopsies of Big Change Management Failures

LSA Global

The third and final nail on the coffin was that they didn’t read their market right – a fatal change management mistake. They were not agile enough. For one, instead of establishing their own online sales site, they partnered with Amazon, a formidable rival. They didn’t pay attention to what consumers wanted.

article thumbnail

The First Step to Fixing U.S. Manufacturing

Harvard Business

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What to Know Before You Sign a Payment-by-Results Contract

Harvard Business

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. And providers want the flexibility to deliver outcomes in the best, most innovative, and most efficient way possible without being micromanaged by the customer. ” Health care.

article thumbnail

2024 Events for Project Managers, Business Leaders, and Industry Professionals

Epicflow

The Forum participants will have an opportunity to learn from inspirational project management leaders as well as attend masterclasses revealing the aspects of delivering sustainable projects, Agile transformation, application of technologies, and more. is the largest Agile conference in Central Europe. PMO London 2024 June, 18-19.

article thumbnail

How Blockchain Will Accelerate Business Performance and Power the Smart Economy - SPONSOR CONTENT FROM MICROSOFT

Harvard Business

Does your organization have the “market power” to implement the scenario? Identify whether your organization has the ability, based on market size and/or influence, to get other parties to participate in a consortium. What transactional data will you have to provide contextual reputational data?